Tag: Lithoplasty

Consider intravascular lithotripsy when treating calcified femoropopliteal arteries

 Treating severely calcified arteries by endovascular means is still a challenge, although atherectomy, stents and lithotripsy are all techniques that are employed. Lithotripsy (also...

Shockwave Medical reports positive results for Lithoplasty in calcified lesions below...

Shockwave Medical has reported positive results from the DISRUPT BTK Study, which were presented at the annual Cardiovascular and Interventional Radiological Society of Europe...

Shockwave Medical Lithoplasty system launched in USA as first patient enrolled...

Shockwave Medical has announced two milestones for its Lithoplasty system for the treatment of calcified plaque in patients with peripheral artery disease (PAD): enrolment...

Shockwave Medical appoints Doug Godshall as president and chief executive officer

Shockwave Medical has announced the appointment of Doug Godshall as president and chief executive officer. Godshall was most recently the chief executive officer and a...

First US patient treated in vascular study of Shockwave Medical Lithoplasty...

PinnacleHealth CardioVascular Institute has enrolled the first US patient in a trial assessing the safety and effectiveness of a new type of approach for...

Shockwave Medical raises US$45 Million in Series C financing to advance...

Shockwave Medical has announced the closing of US$45 million in Series C financing led by Sectoral Asset Management, with participation from mutual funds advised...

Shockwave Medical announces plans for “largest ever” calcified peripheral artery disease...

Shockwave Medical has announced plans for DISRUPT PAD III—what is claims is the “largest ever” multicentre randomised study to exclusively enrol patients with calcified...

Six-month Shockwave Medical Disrupt PAD data show “consistent and predictable” procedural...

Shockwave Medical has announced positive clinical results from the pooled DISRUPT PAD Study, a single-arm, two-phase, multicentre study evaluating the safety and performance of...

Shockwave Medical Lithoplasty system is cleared by the FDA

Shockwave Medica has announced clearance from the US Food and Drug Administration (FDA) of the Lithoplasty system for the treatment of calcified plaque in...

CE mark approval for Lithoplasty balloon catheters for the treatment of...

Lithoplasty is a novel balloon-based technology that utilises integrated lithotripsy, a pulsatile mechanical energy commonly used to break up kidney stones, to disrupt both superficial and deep calcium and normalise vessel wall compliance prior to low-pressure balloon dilatation.